Literature DB >> 31190110

Mapping versus source methods for quantifying myocardial T1 in controls and in repaired tetralogy of Fallot: interchangeability and reproducibility in children.

Christopher Z Lam1, Joseph J Pagano2, Deane Yim2, Shi-Joon Yoo3,2, Mike Seed3,2, Lars Grosse-Wortmann3,2.   

Abstract

BACKGROUND: Myocardial T1 relaxometry can be performed by contouring on individual T1-weighted source images (source method) or on a single T1 map (mapping method).
OBJECTIVE: This study compares (a) agreement between native T1 and extracellular volume results of the two methods and (b) interobserver reproducibility of the two methods in children without heart disease and those with tetralogy of Fallot (TOF).
MATERIALS AND METHODS: We retrospectively analyzed pediatric patients (controls and those with repaired TOF) with cardiac magnetic resonance examinations including extracellular volume quantification using the modified Look-Locker inversion recovery (MOLLI) sequence. We compared native T1 and extracellular volume of the entire left ventricle and interventricular septum derived using the source and the mapping approaches.
RESULTS: In the control group (n=25, median age 14.0 years, interquartile range [IQR] 11.5-16.5 years), the mapping method produced lower native T1 values than the source method in the interventricular septum (mean difference ± standard deviation [SD] = 12±15 ms, P<0.001). In the TOF group (n=50, median age 13.3 years, IQR 9.9-15.0 years), the mapping method produced lower values for native T1 and extracellular volume in the interventricular septum (mean difference 9±14 ms and 0.6±1.1%, P<0.001). In 6-12% of the children, differences were >3 standard deviations from the mean difference. Interobserver reproducibility between the two methods by intraclass correlation coefficients were clinically equivalent.
CONCLUSION: T1 and extracellular volume values generated by the source and mapping methods show systematic differences and can vary significantly in an individual child, and thus cannot be used interchangeably in clinical practice. The source method might allow for easier detection and, in some cases, mitigation of artifacts that are not infrequent in children and can be difficult to appreciate on the T1 map.

Entities:  

Keywords:  Children; Heart; Magnetic resonance imaging; Post-processing; Relaxometry; Reproducibility; T1 mapping; Tetralogy of Fallot

Mesh:

Substances:

Year:  2019        PMID: 31190110     DOI: 10.1007/s00247-019-04428-y

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  26 in total

Review 1.  Myocardial T1 mapping in pediatric and congenital heart disease.

Authors:  Eugénie Riesenkampff; Daniel R Messroghli; Andrew N Redington; Lars Grosse-Wortmann
Journal:  Circ Cardiovasc Imaging       Date:  2015-02       Impact factor: 7.792

2.  New mechanistic and therapeutic targets for pediatric heart failure: report from a National Heart, Lung, and Blood Institute working group.

Authors:  Kristin M Burns; Barry J Byrne; Bruce D Gelb; Bernhard Kühn; Leslie A Leinwand; Seema Mital; Gail D Pearson; Mark Rodefeld; Joseph W Rossano; Brian L Stauffer; Michael D Taylor; Jeffrey A Towbin; Andrew N Redington
Journal:  Circulation       Date:  2014-07-01       Impact factor: 29.690

3.  Myocardial ECV Fraction Assessed by CMR Is Associated With Type of Hemodynamic Load and Arrhythmia in Repaired Tetralogy of Fallot.

Authors:  Chun-An Chen; Susan M Dusenbery; Anne Marie Valente; Andrew J Powell; Tal Geva
Journal:  JACC Cardiovasc Imaging       Date:  2015-12-09

4.  Pediatric Fontan patients are at risk for myocardial fibrotic remodeling and dysfunction.

Authors:  Atsuko Kato; Eugénie Riesenkampff; Deane Yim; Shi-Joon Yoo; Mike Seed; Lars Grosse-Wortmann
Journal:  Int J Cardiol       Date:  2017-04-22       Impact factor: 4.164

5.  Adiabatic inversion pulses for myocardial T1 mapping.

Authors:  Peter Kellman; Daniel A Herzka; Michael Schacht Hansen
Journal:  Magn Reson Med       Date:  2013-05-30       Impact factor: 4.668

6.  Diffuse myocardial fibrosis evaluation using cardiac magnetic resonance T1 mapping: sample size considerations for clinical trials.

Authors:  Songtao Liu; Jing Han; Marcelo S Nacif; Jacquin Jones; Nadine Kawel; Peter Kellman; Christopher T Sibley; David A Bluemke
Journal:  J Cardiovasc Magn Reson       Date:  2012-12-28       Impact factor: 5.364

7.  Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance.

Authors:  Silvia Pica; Daniel M Sado; Viviana Maestrini; Marianna Fontana; Steven K White; Thomas Treibel; Gabriella Captur; Sarah Anderson; Stefan K Piechnik; Matthew D Robson; Robin H Lachmann; Elaine Murphy; Atul Mehta; Derralyn Hughes; Peter Kellman; Perry M Elliott; Anna S Herrey; James C Moon
Journal:  J Cardiovasc Magn Reson       Date:  2014-12-05       Impact factor: 5.364

8.  Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI).

Authors:  Daniel R Messroghli; James C Moon; Vanessa M Ferreira; Lars Grosse-Wortmann; Taigang He; Peter Kellman; Julia Mascherbauer; Reza Nezafat; Michael Salerno; Erik B Schelbert; Andrew J Taylor; Richard Thompson; Martin Ugander; Ruud B van Heeswijk; Matthias G Friedrich
Journal:  J Cardiovasc Magn Reson       Date:  2017-10-09       Impact factor: 5.364

9.  Diffuse myocardial fibrosis in the systemic right ventricle of patients late after Mustard or Senning surgery: an equilibrium contrast cardiovascular magnetic resonance study.

Authors:  Carla M Plymen; Dan M Sado; Andrew M Taylor; Aidan P Bolger; Pier D Lambiase; Marina Hughes; James C Moon
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2013-02-06       Impact factor: 6.875

10.  Myocardial T1 and T2 mapping at 3 T: reference values, influencing factors and implications.

Authors:  Florian von Knobelsdorff-Brenkenhoff; Marcel Prothmann; Matthias A Dieringer; Ralf Wassmuth; Andreas Greiser; Carsten Schwenke; Thoralf Niendorf; Jeanette Schulz-Menger
Journal:  J Cardiovasc Magn Reson       Date:  2013-06-18       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.